Levact (bendamustine): Reviews and patient testimonials
Back to the list of medications
Medication indications
Levact 2.5 mg/ml powder for concentrate for solution for infusion
First-line treatment of chronic lymphocytic leukaemia (Binet stage B or C) in patients for whom fludarabine combination chemotherapy is not appropriate.
Indolent non-Hodgkin's lymphomas as monotherapy in patients who have progressed during or within 6 months following treatment with rituximab or a rituximab containing regimen.
Front line treatment of multiple myeloma (Durie-Salmon stage II with progress or stage III) in combination with prednisone for patients older than 65 years who are not eligible for autologous stem cell transplantation and who have clinical neuropathy at time of diagnosis precluding the use of thalidomide or bortezomib containing treatment.
Route of administration: Injectable
Molecule: bendamustine
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.